Diabetes | CHOP Research Institute
 

Diabetes

Off Campus: Reaching New Heights With Crossword Puzzles and Radio-controlled Planes

Published on
Jul 29, 2022
in Cornerstone Blog
Reaching New Heights With Crossword Puzzles, Radio-controlled Planes
Dr. Levine’s great pastimes outside of his endocrinology lab are crossword puzzles and flying radio-controlled airplanes with his grandsons.

Celebrate Diversity Month: Q&A With Featured Research Trainee, Anna Ada Dattoli, PhD

Published on
Apr 28, 2022
in Cornerstone Blog
Celebrate Diversity Month: Q&A With Trainee Anna Ada Dattoli, PhD
Our Featured Trainee for April, Anna Ada Dattoli, PhD, discusses Celebrate Diversity Month and her research on diabetes.
Jacquelyn Anne Hatch-Stein, MD
Jacquelyn Anne Hatch-Stein

Dr. Hatch-Stein's research interests include diabetes, thyroid disorders, and disorders of growth and puberty. Recent clinical research projects include "Bone Health and Cardiovascular Risk in Turner Syndrome" and "Patterns of Height Velocity in Down Syndrome."

E-mail:
hatchsteinj [at] chop.edu

Teplizumab in New-Onset Type 1 Diabetes

Teplizumab in New-Onset Type 1 DiabetesTeplizumab in New-Onset Type 1 Diabetes

This is a study that investigates whether an IV medication (teplizumab) will slow or halt the progression of type 1 diabetes in children and adolescents (ages 8 - 17 years).

The Charisma Study

The Charisma Study

We are currently enrolling adolescents ages 15-21 of South Asian ancestry, African American ancestry, and European American or "White" ancestry.

Ertugliflozin for Children and Adolescents with Type 2 Diabetes

Ertugliflozin for Children and Adolescents with Type 2 Diabetes

You are invited to take part in a voluntary research trial because you have type 2 diabetes and are between the ages of 10 and 17 years.

Shah Laboratory

Shah Lab

The Shah Lab investigates obesity and its related complications. Current work includes clinical and translational studies exploring the pathophysiology and modulation of obesity-related adipose tissue and systemic inflammation using human cell lines and clinical trials.

Pinney Laboratory

Pinney Lab

Dr. Pinney’s research focuses on determining the molecular mechanisms that link an adverse intrauterine milieu to the development of diabetes and obesity later in life.

Chronic Incretin-based therapy in Cystic Fibrosis (Aim 2)

Chronic Incretin-based therapy in Cystic Fibrosis (Aim 2)

The purpose of this research study is to examine and understand the various mechanisms that contribute to Cystic Fibrosis Related Diabetes and gain a better understanding of potential means to treat Cystic Fibrosis Related Diabetes.

Long Laboratory

Long Lab

The research focus in the Long Lab centers on understanding how the mammalian skeleton is formed and maintained in a functional state throughout life.